Ahmad Anam, Baker Donica L
Internal Medicine, St. Luke's Hospital, Chesterfield, USA.
Rheumatology, St. Luke's Hospital, Chesterfield, USA.
Cureus. 2022 Jul 6;14(7):e26617. doi: 10.7759/cureus.26617. eCollection 2022 Jul.
Polymyalgia rheumatica (PMR) is characterized by myalgia and severe stiffness with decreased range of motion in the shoulder and pelvic girdles. The efficacy of the BNT 162b2 Pfizer vaccine has been proven and has been well-tolerated by patients; however, some instances of PMR have been reported after the COVID-19 vaccine. We are writing a case of a new-onset PMR in a 72-year-old woman with typical findings after receiving a booster dose of the BNT 162b2 Pfizer vaccine. This case report highlights that PMR should be in the differential diagnosis of myalgias caused by the vaccine.
风湿性多肌痛（PMR）的特征是肌痛和严重僵硬，同时肩部和骨盆带的活动范围减小。辉瑞公司的BNT 162b2疫苗的疗效已得到证实，且患者耐受性良好；然而，在接种新冠疫苗后已有一些PMR病例的报告。我们撰写了一例72岁女性在接种辉瑞公司的BNT 162b2疫苗加强针后出现新发PMR且有典型表现的病例。本病例报告强调，PMR应列入疫苗所致肌痛的鉴别诊断范围。
